| Full text | |
| Author(s): |
Audrey Borghi Silva
[1]
;
Valéria Amorim Pires Di Lorenzo
[2]
;
Maurício Jamami
[3]
;
Luciana Maria Malosá Sampaio
[4]
;
Aureluce Demonte
[5]
;
Leonardo Cardello
[6]
;
Dirceu Costa
[7]
Total Authors: 7
|
| Affiliation: | [1] UFSCar. Laboratório de Eletromiografia e Espirometria
[2] UNIARA. Unidade Cardiorrespiratória
[3] UFSCar. Laboratório de Eletromiografia e Espirometria
[4] UFSCar. Laboratório de Eletromiografia e Espirometria
[5] UNESP. Departamento de Alimentos e Nutrição
[6] UNESP. Departamento de Alimentos e Nutrição
[7] UFSCar. Laboratório de Eletromiografia e Espirometria
Total Affiliations: 7
|
| Document type: | Journal article |
| Source: | J. Pneumologia; v. 29, n. 6, p. 379-385, 2003-12-00. |
| Abstract | |
BACKGROUND: Patients with chronic obstructive pulmonary disease usually present intolerance to physical exertion due to ventilatory limitation. L-carnitine has been used to enhance aerobic capacity in patients with chronic diseases, but no study seems to be available for this patient population. OBJECTIVE: To evaluate the influence of L-carnitine supplementation (2 g/day) in chronic obstructive pulmonary disease patients undergoing physical training three times a week for six weeks. METHOD: Patients (mean age 69 ± 7 years, n = 30) with stable chronic obstructive pulmonary disease and < 65% of predicted forced expiratory volume in 1 second (FEV1) were separated into three groups of 10 patients each. Group 1 (G1, n = 10) received physical training and L-carnitine (2 g/day), group 2 (G2, n = 10) received physical training and placebo, and group 3 (G3, n = 10) received only L-carnitine (2 g/day). Spirometry and a 6-minute walking distance test were performed before and after intervention. Plasma levels of free carnitine were measured at the beginning and end of the study. RESULTS: A significant increase in walking distance was found only in G1 and G2 (421 ± 100 to 508 ± 80.7 and 496 ± 78.7 to 526 ± 64.3 respectively). In addition, heart rates during physical training sessions were found to be significantly lower in G1 when compared to G2. There were no significant changes in spirometric variables, oxygen saturation or dyspnea in any group. Plasma levels of free L-carnitine were found to increase only in G3 (59.2 ± 13.8 to 102.3 ± 15.3 mmol/L). CONCLUSION: Oral L-carnitine supplementation combined with physical training may improve tolerance to physical exertion in chronic obstructive pulmonary disease patients. (AU) | |